RespireRx Pharmaceuticals Inc (OTCMKTS:RSPI) is well known for its work on the development of innovative treatments that are meant for tackling conditions that are brought about by neuronal signalling. Traders Corner RSPI stock is trading below the 20-Day and 50-Day Moving averages of $0.1710 and $0.0206 respectively. Moreover, the stock is trading below the 200-Day …